| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |